Test Price
2,800 AED✅ Home Collection Available
LPL Gene Hyperlipoproteinemia Type 1 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
This advanced genetic diagnostic test is recommended for UAE residents to diagnose Type 1 Hyperlipoproteinemia with 99.9% accuracy. Services include ISO-certified VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection, with telephonic post-test guidance from a Consultant Medical Genetics.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection (daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The LPL Gene Hyperlipoproteinemia Type 1 NGS Test employs Next-Generation Sequencing (NGS) to detect pathogenic variants in the LPL gene causing familial chylomicronemia syndrome and severe hypertriglyceridemia. In the UAE, this genetic analysis provides definitive diagnosis for suspected Type 1 hyperlipoproteinemia, enabling targeted lipid management and family cascade screening.
Our Test vs. Closest Alternative
| Feature | Our Test (NGS) | Standard Biochemical Lipid Panel |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity | Variable; indirect markers only |
| Method | Next-Generation Sequencing (NGS) full LPL gene coverage | Lipid profile (triglycerides, cholesterol subclasses) |
| Turnaround | 3–4 Weeks | Same day |
| Clinical Utility | Confirms genetic cause, guides targeted therapy & family screening | Detection, not confirmation of aetiology |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I advise that a positive LPL gene result must be correlated with lipid profiles and family history. A negative result does not exclude other genetic or secondary causes of hypertriglyceridemia. Always integrate findings with comprehensive clinical evaluation," says Lina Osama Zaki Quteineh (DHA License: 9294403). This test supports but does not replace clinical judgment.
Clinical Advisory: Medication and Safety
Do not discontinue any prescribed lipid-lowering agents (fibrates, omega-3 concentrates, insulin) or other medications without consulting your physician. Genetic testing is part of a comprehensive care plan, not a standalone therapeutic directive. Continue all current therapies unless directed otherwise.
Exclusion Criteria & Safety Red Flags
- Recent acute pancreatitis or hospitalization – stabilize first; test only upon physician clearance.
- Current use of fibrates, omega-3 concentrates, or insulin: continue as prescribed; do not alter dosage for testing.
- Emergency Red Flags: Seek immediate medical attention for severe abdominal pain, altered consciousness, eruptive xanthomas, or triglyceride levels persistently above 11.3 mmol/L (1000 mg/dL).
Patient FAQ & Clinical Guidance
1. What does the LPL Gene Hyperlipoproteinemia Type 1 NGS test diagnose?
This test detects pathogenic DNA variants in the LPL gene causing familial chylomicronemia syndrome, leading to extremely high triglycerides and increased risk of pancreatitis. It provides a definitive molecular diagnosis for appropriate clinical management.
2. How is the sample collected in the UAE?
We offer premium VIP Mobile Phlebotomy with temperature-controlled cold-chain logistics. A trained phlebotomist collects a small blood sample (EDTA tube or FTA card) from your home, ensuring minimal discomfort and specimen integrity.
3. Can asymptomatic individuals with a family history take this test?
Yes, presymptomatic genetic screening is recommended for individuals with a family history of severe hypertriglyceridemia or recurrent pancreatitis. Early detection enables lifestyle modifications and proactive medical surveillance.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic and personal data are encrypted, securely stored, and handled under DHA standards.
Clinical & Logistical Metadata
| Test Name | LPL Gene Hyperlipoproteinemia Type 1 NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) – Full LPL gene coverage |
| ICD-10-CM Code | E78.3 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians